Major Shareholders

As at 1st June 2010, the issued share capital of FuturaGene plc is 58,972,239 ordinary shares of £0.005p each.

As of that date the number of shares not in public hands as defined in the AIM rules was, in aggregate 17,006,093, representing 28.84% of the issued share capital.

Holdings of major shareholders, as registered on 1st June 2010, are listed below:

• Apollo Nominees CRE ACCT (3.30%)
• Monument Capital LLC (4.24%)
• Florinvest S.A. (4.58%)
• Credit Suisse Client Nominees (UK) Limited (5.09%)
• Mr. Mark Pritchard (5.72%)
• Mr. Benjamin Anderson (5.77%)
• International Institute for Bio-Science Research Development (7.42%)
• Pershing Nominees Limited A/c PSL981 (8.34%)
• Pershing Nominees Limited A/c LSCLT (11.39%)